QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase

ISSN： 1054-2523

Source： Medicinal Chemistry Research, Vol.20, Iss.7, 2011-09, pp. : 877-886

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials of Poly(ADP-Ribose) Polymerase Inhibitors for Cancer Therapy: A Review

Reviews on Recent Clinical Trials, Vol. 10, Iss. 4, 2015-12 ,pp. : 326-339

Bentham Science Publishers

Access to resources Recommend Favorite

Novel poly (ADP‐ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repair

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1190-1198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synergistic cytotoxicity of the poly (ADP‐ribose) polymerase inhibitor ABT‐888 and temozolomide in dual‐drug targeted magnetic nanoparticles

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1430-1441

John Wiley & Sons Inc

Access to resources Recommend Favorite

The world according to poly(ADP-ribose) polymerase (PARP)—update 2006

By Barth Eberhard Radermacher Peter Szabó Csaba

Intensive Care Medicine, Vol. 32, Iss. 10, 2006-10 ,pp. : 1470-1474

Springer Publishing Company

Access to resources Recommend Favorite

Autoantibodies to Poly(ADP-Ribose) Polymerase in Centenarians: A Reappraisal of Grabar’s Hypothesis

Gerontology, Vol. 55, Iss. 4, 2009-04 ,pp. : 427-429

Karger

Access to resources Recommend Favorite